Putting Menopause on Ice: The Cryomedicalization of Reproductive Aging

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Putting Menopause on Ice : The Cryomedicalization of Reproductive Aging. / Kroløkke, Charlotte; Bach, Anna Sofie.

In: New Genetics and Society, 07.06.2020.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Kroløkke, C & Bach, AS 2020, 'Putting Menopause on Ice: The Cryomedicalization of Reproductive Aging', New Genetics and Society. https://doi.org/10.1080/14636778.2020.1775563

APA

Kroløkke, C., & Bach, A. S. (2020). Putting Menopause on Ice: The Cryomedicalization of Reproductive Aging. New Genetics and Society. https://doi.org/10.1080/14636778.2020.1775563

Vancouver

Kroløkke C, Bach AS. Putting Menopause on Ice: The Cryomedicalization of Reproductive Aging. New Genetics and Society. 2020 Jun 7. https://doi.org/10.1080/14636778.2020.1775563

Author

Kroløkke, Charlotte ; Bach, Anna Sofie. / Putting Menopause on Ice : The Cryomedicalization of Reproductive Aging. In: New Genetics and Society. 2020.

Bibtex

@article{f90b1eb893c44c08a90a06d3e034ab00,
title = "Putting Menopause on Ice: The Cryomedicalization of Reproductive Aging",
abstract = "This article examines how cryopreserved ovarian tissue is potentiated as a menopausal prevention and/or treatment cure. Based on a multi-sited ethnographic study, the article empirically foregrounds scientific accounts and interviews with Danish female cancer patients who had ovarian tissue preserved. Using situational analysis as a methodological approach along with analytical perspectives on potentiality, we identify three framings revealing how cryotechnology intervenes with women{\textquoteright}s reproductive aging: Cryopreservation as a risk management technology, as an optimizing technology, and as a synchronization technology. The article shows how the ability to cryopreserve ovarian tissue in order to reverse menopause draws upon an understanding of menopause as not only controllable but of cryopreservation as a resource-wise technology that manages women{\textquoteright}s aging bodies. Suggesting “cryomedicalization” as a term, the article highlights how cryopreserved ovarian tissue (re)constitutes normative temporalities, produces new understandings of cryo-restoration and raises questions related to the cryopolitics of women{\textquoteright}s aging.",
author = "Charlotte Krol{\o}kke and Bach, {Anna Sofie}",
year = "2020",
month = jun,
day = "7",
doi = "10.1080/14636778.2020.1775563",
language = "English",
journal = "New Genetics and Society",
issn = "1463-6778",
publisher = "Routledge",

}

RIS

TY - JOUR

T1 - Putting Menopause on Ice

T2 - The Cryomedicalization of Reproductive Aging

AU - Kroløkke, Charlotte

AU - Bach, Anna Sofie

PY - 2020/6/7

Y1 - 2020/6/7

N2 - This article examines how cryopreserved ovarian tissue is potentiated as a menopausal prevention and/or treatment cure. Based on a multi-sited ethnographic study, the article empirically foregrounds scientific accounts and interviews with Danish female cancer patients who had ovarian tissue preserved. Using situational analysis as a methodological approach along with analytical perspectives on potentiality, we identify three framings revealing how cryotechnology intervenes with women’s reproductive aging: Cryopreservation as a risk management technology, as an optimizing technology, and as a synchronization technology. The article shows how the ability to cryopreserve ovarian tissue in order to reverse menopause draws upon an understanding of menopause as not only controllable but of cryopreservation as a resource-wise technology that manages women’s aging bodies. Suggesting “cryomedicalization” as a term, the article highlights how cryopreserved ovarian tissue (re)constitutes normative temporalities, produces new understandings of cryo-restoration and raises questions related to the cryopolitics of women’s aging.

AB - This article examines how cryopreserved ovarian tissue is potentiated as a menopausal prevention and/or treatment cure. Based on a multi-sited ethnographic study, the article empirically foregrounds scientific accounts and interviews with Danish female cancer patients who had ovarian tissue preserved. Using situational analysis as a methodological approach along with analytical perspectives on potentiality, we identify three framings revealing how cryotechnology intervenes with women’s reproductive aging: Cryopreservation as a risk management technology, as an optimizing technology, and as a synchronization technology. The article shows how the ability to cryopreserve ovarian tissue in order to reverse menopause draws upon an understanding of menopause as not only controllable but of cryopreservation as a resource-wise technology that manages women’s aging bodies. Suggesting “cryomedicalization” as a term, the article highlights how cryopreserved ovarian tissue (re)constitutes normative temporalities, produces new understandings of cryo-restoration and raises questions related to the cryopolitics of women’s aging.

UR - https://portal.findresearcher.sdu.dk/en/publications/82a2503c-a64f-4178-8a51-fa09814f29bf

U2 - 10.1080/14636778.2020.1775563

DO - 10.1080/14636778.2020.1775563

M3 - Journal article

JO - New Genetics and Society

JF - New Genetics and Society

SN - 1463-6778

ER -

ID: 289159319